Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

Recruiting now

Conditions studied: Chronic Low-back Pain, Vertebrogenic Pain Syndrome

In brief

Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.

Key facts

Study ID
NCT06827262
Run by
Boston Scientific Corporation
People needed
1500
Starts
2025-03-26
Expected to finish
2034-07-01
Last updated by the study team
2026-08-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.